Form 4 for FDMT 4D Molecular Therapeutics, Inc.
Accepted 2024-02-12 00:00:00 ET · period of report 2024-02-08 · accession 0000950170-24-014119 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2024-02-12 | 2024-02-08 | FDMT | Bizily Scott | CLO | S - Sale+OE | $27.50 | -6,244 | 1,737 | -78% | -$171.7K |
| DMT | 2024-02-12 | 2024-02-08 | FDMT | Bizily Scott | CLO | M - OptEx | $10.18 | +6,244 | 3,069 | New | +$63.6K |
| DMT | 2024-02-12 | 2024-02-08 | FDMT | Bizily Scott | CLO | M - OptEx | $0.00 | -6,244 | 23.0K | -21% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-08 | S | D | 1,996 | $27.50 | 1,737 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-08 | M | A | 1,996 | $15.78 | 3,733 | D | — | — | |
| 3 | Common | Common Stock | 2024-02-08 | S | D | 2,916 | $27.50 | 1,737 | D | — | — | |
| 4 | Common | Common Stock | 2024-02-08 | M | A | 2,916 | $8.04 | 4,653 | D | — | — | |
| 5 | Common | Common Stock | 2024-02-08 | M | A | 1,332 | $6.49 | 3,069 | D | — | — | |
| 6 | Common | Common Stock | 2024-02-08 | S | D | 1,332 | $27.50 | 1,737 | D | — | — | |
| 7 | Derivative | Stock Option (Right to Buy) | 2024-02-08 | M | D | 1,332 | $0.00 | 17,043 | D | $6.49 · — to 2032-06-17 | 1,332 Common Stock | (F2) The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of June 16, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company. |
| 8 | Derivative | Stock Option (Right to Buy) | 2024-02-08 | M | D | 2,916 | $0.00 | 45,834 | D | $8.04 · — to 2032-08-31 | 2,916 Common Stock | (F3) The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of September 1, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company. |
| 9 | Derivative | Stock Option (Right to Buy) | 2024-02-08 | M | D | 1,996 | $0.00 | 23,004 | D | $15.78 · — to 2032-01-31 | 1,996 Common Stock | (F4) The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of March 1, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company. |